The National Institutes of Health (NIH) announced that the Rapid Acceleration of Diagnostics (RADx) program has outlined a framework to manufacture 6 million diagnostic tests per day by the end of 2020 with support from the Office of the Assistant Secretary for Health, the Biomedical Advanced Research and Development Authority (BARDA), and the Department of Defense.
The program consists of four main components:
- RADx Tech aims to identify, accelerate development, scale up, and deploy innovative point-of-care technologies throughout the fall of 2020. Through a “shark tank” model, the NIH has received over 600 applications, with 27 projects advancing to phase 1, and one project advancing to phase 2.
- RADx Advanced Technology Platforms will support the scale up of more advanced technologies that can achieve immediate and substantial increase in manufacturing capacity.
- RADx Radical focuses on nontraditional approaches for diagnostics tests that have a longer timeline until deployment.
- RADx Underserved Populations will establish community-engaged implementation projects to improve access to testing in underserved populations.